Loading clinical trials...
Loading clinical trials...
Randomized Trial Evaluating Effect of Outpatient Hydroxychloroquine on Reducing Hospital Admissions in Pregnant Women With SARS-CoV-2 Infection: HyPreC Trial
Conditions
Interventions
hydroxychloroquine sulfate 200 MG
Placebo oral tablet
Start Date
May 1, 2020
Primary Completion Date
May 1, 2020
Completion Date
May 1, 2020
Last Updated
June 25, 2020
NCT06976632
NCT06082518
NCT07221162
NCT06523543
NCT06631287
NCT06357546
Lead Sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions